RESEARCH-USE BIOSIMILAR ANTIBODY
Ensituximab
Monoclonal antibody · IgG1
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer.
TARGETMUC5A
YMonoclonal antibody
CATALOGSC-BS-576
CATALOG NUMBERSC-BS-576
MOLECULAR WEIGHTApprox. 142.82 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer.
Ensituximab is a recombinant research-use antibody directed against MUC5A.